Akt/mTOR signaling pathway dysregulation has been studied in neurological disorders such as AD, traumatic brain injury, brain tumors, epilepsy, autism, diabetes, and aging process (21, 28, 42, 43). This evidence concerns the gene AKT1 and epilepsy.